{"id":"W3029194496","doi":"10.1200/jco.2020.38.15_suppl.4003","title":"Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"National Institutes of Health","keywords":"Medicine; Celecoxib; FOLFOX; Internal medicine; Hazard ratio; Colorectal cancer; Oxaliplatin; Clinical endpoint; Irinotecan; Fluorouracil; Oncology; Aspirin; Randomized controlled trial; Cancer; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002293659,0.000624572,0.001044534,0.0004337446,0.0002573232,0.0007209332,0.0003631794,0.0006926054,0.002182658],"category_scores_gemma":[0.001743128,0.0002129434,0.001787603,0.0006160323,0.0002998961,0.0003579386,0.0003425799,0.001276087,0.0002949253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001001802,"about_ca_system_score_gemma":0.001684749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005335391,"about_ca_topic_score_gemma":0.01258965,"domain_scores_codex":[0.9995042,0.000266242,0.00003812317,0.00005145869,0.00005990705,0.00008005974],"domain_scores_gemma":[0.9989833,0.0002268424,0.0002262129,0.00005689635,0.0001013841,0.0004052785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8292918,0.006890219,0.006297472,0.001805293,0.002748281,0.0001364192,0.0001061167,0.0009309178,0.003805753,0.0001541527,0.007700659,0.1401329],"study_design_scores_gemma":[0.6945734,0.2242602,0.05747891,0.0004857727,0.006462809,0.0002398243,0.00008213159,0.0005293777,0.002075605,0.0001592469,0.0136216,0.00003114258],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9282022,0.05771265,0.0003616488,0.002635854,0.000494188,0.001217441,0.003075322,0.00008866803,0.006211984],"genre_scores_gemma":[0.9607708,0.0218534,0.001126197,0.002835786,0.0005299012,0.0006940478,0.007410693,0.00002679755,0.00475226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005335391,"threshold_uncertainty_score":0.0121302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.120298348513323,"score_gpt":0.4351693026124021,"score_spread":0.3148709540990792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}